Bristol-Myers Squibb logo

Bristol-Myers Squibb dividend paid (ttm)NYSE: BMY

Dividend paid (TTM)

$478.00 B
+$2.00 B+0.42%

30 June 2024

new highvs 3 years high
+10.7%vs 3 years low
94.87%vs. sector
Performance
Most recent+0.4%
1 year+1.1%
3 years+10.7%
5 years+79.4%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (TTM) performance

Most recent change
BMY+0.4%
MDT-0.6%
GILD+0.7%
ELV+2.1%
1 year change
BMY+1.1%
MDT+0.0%
GILD+2.0%
ELV+9.4%
3 years change
BMY+10.7%
MDT+12.0%
GILD+8.1%
ELV+39.1%
5 years change
BMY+79.4%
MDT+30.7%
GILD+22.2%
ELV+83.1%

Dividend paid (TTM) performance

BMYMDTGILDVRTXBSXELVREGN
Most recent+0.4%-0.6%+0.7%--+2.1%-
1 year+1.1%+0.0%+2.0%--+9.4%-
3 years+10.7%+12.0%+8.1%--+39.1%-
5 years+79.4%+30.7%+22.2%--+83.1%-
FAQ

What is Bristol-Myers Squibb dividend paid (ttm)?

Bristol-Myers Squibb dividend paid (ttm) is $478.00 B

What is Bristol-Myers Squibb dividend paid (ttm) compared to its all-time maximum value?

Bristol-Myers Squibb dividend paid (ttm) is 100% of its all-time maximum value

What is Bristol-Myers Squibb dividend paid (ttm) compared to other companies from its sector (Healthcare)?

Bristol-Myers Squibb dividend paid (ttm) is higher than 94.87% of the companies in the same sector (Healthcare)

How has Bristol-Myers Squibb dividend paid (ttm) changed over the year?

Over the past year, Bristol-Myers Squibb dividend paid (ttm) has increased by 1.1%. During the same period, Medtronic has increased by 0.0%, Gilead Sciences has risen by 2.0%, Elevance Health has risen by 9.4%

How has Bristol-Myers Squibb dividend paid (ttm) changed over the 3 years?

During the last 3 years, Bristol-Myers Squibb dividend paid (ttm) has increased by 10.7%. Over the same period, Medtronic has increased by 12.0%, Gilead Sciences has risen by 8.1%, Elevance Health has risen by 39.1%

How has Bristol-Myers Squibb dividend paid (ttm) changed over the 5 years?

For the past 5 years, Bristol-Myers Squibb dividend paid (ttm) has increased by 79.4%. In the same period, Medtronic has increased by 30.7%, Gilead Sciences has risen by 22.2%, Elevance Health has risen by 83.1%